PR Newswire Clinical TrialsOriginal article
Epicore Biosystems and MECFA Announce Collaboration to Expand Access to Wearable Sweat Chloride Testing for Cystic Fibrosis
PartnershipWearable Sweat Chloride TestingPositive
AI Analysis
Summary
Epicore Biosystems and MECFA announced a collaboration to expand access to wearable sweat chloride testing for cystic fibrosis monitoring in the Middle East and other underserved regions.
Importance:5/10
Sentiment:
0.60
partnershipwearable technologycystic fibrosisdiagnosticexpansionMiddle East
Read the original article
Published by PR Newswire Clinical Trials on October 6, 2026 1:30 PM
